Despite inferior revenue outlook, the company's P/S ratio re...
Despite inferior revenue outlook, the company's P/S ratio remains stable. However, without positive change, the current P/S ratio may not be sustainable. Investors may face disappointment if the P/S falls in line with the growth outlook.
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) 26% Price Boost Is Out Of Tune With Revenues
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment